BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Latest reported BRTX revenue for 2025-12-31 was $359.7K. Net income was -$14.2M. Revenue was down 10.3% from 2024-12-31 to 2025-12-31. BRTX currently screens at market cap $10.2M.
Use this BRTX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the BRTX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the BRTX SEC filings page. Lician reads the product cache first so this HTML stays unique to BioRestorative Therapies Inc even when a live quote feed is slow.
Latest cached year on this hub. Full BRTX income, balance, and cash tables.